| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.3 |